nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—Hepatic function abnormal—Teniposide—lymphatic system cancer	0.0213	0.0213	CcSEcCtD
Midodrine—Hyperaesthesia—Bleomycin—lymphatic system cancer	0.0211	0.0211	CcSEcCtD
Midodrine—Scotoma—Carmustine—lymphatic system cancer	0.019	0.019	CcSEcCtD
Midodrine—Sleep disorder—Fludarabine—lymphatic system cancer	0.0189	0.0189	CcSEcCtD
Midodrine—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.0166	0.0166	CcSEcCtD
Midodrine—Drug interaction—Carmustine—lymphatic system cancer	0.0156	0.0156	CcSEcCtD
Midodrine—Drug interaction—Vincristine—lymphatic system cancer	0.0149	0.0149	CcSEcCtD
Midodrine—Hepatic enzyme increased—Mitoxantrone—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Midodrine—Stomatitis—Teniposide—lymphatic system cancer	0.014	0.014	CcSEcCtD
Midodrine—Dysuria—Fludarabine—lymphatic system cancer	0.0133	0.0133	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.0125	0.0125	CcSEcCtD
Midodrine—Stomatitis—Fludarabine—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Midodrine—Skin disorder—Mechlorethamine—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Midodrine—Flushing—Teniposide—lymphatic system cancer	0.012	0.012	CcSEcCtD
Midodrine—Chills—Teniposide—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Midodrine—Erythema multiforme—Fludarabine—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Midodrine—Agitation—Teniposide—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Midodrine—Chills—Fludarabine—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Midodrine—Hypertension—Teniposide—lymphatic system cancer	0.0097	0.0097	CcSEcCtD
Midodrine—Urinary retention—Vincristine—lymphatic system cancer	0.00953	0.00953	CcSEcCtD
Midodrine—Confusional state—Teniposide—lymphatic system cancer	0.00925	0.00925	CcSEcCtD
Midodrine—Agitation—Fludarabine—lymphatic system cancer	0.00908	0.00908	CcSEcCtD
Midodrine—Stomatitis—Bleomycin—lymphatic system cancer	0.00903	0.00903	CcSEcCtD
Midodrine—Tachycardia—Teniposide—lymphatic system cancer	0.00895	0.00895	CcSEcCtD
Midodrine—Pruritus—Mechlorethamine—lymphatic system cancer	0.0088	0.0088	CcSEcCtD
Midodrine—Dyspnoea—Teniposide—lymphatic system cancer	0.00818	0.00818	CcSEcCtD
Midodrine—Confusional state—Fludarabine—lymphatic system cancer	0.00813	0.00813	CcSEcCtD
Midodrine—Dysuria—Vincristine—lymphatic system cancer	0.0081	0.0081	CcSEcCtD
Midodrine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.0079	0.0079	CcSEcCtD
Midodrine—Stomatitis—Carmustine—lymphatic system cancer	0.00788	0.00788	CcSEcCtD
Midodrine—Rash—Mechlorethamine—lymphatic system cancer	0.00784	0.00784	CcSEcCtD
Midodrine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00784	0.00784	CcSEcCtD
Midodrine—Flushing—Bleomycin—lymphatic system cancer	0.00772	0.00772	CcSEcCtD
Midodrine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00756	0.00756	CcSEcCtD
Midodrine—Stomatitis—Vincristine—lymphatic system cancer	0.00753	0.00753	CcSEcCtD
Midodrine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.0075	0.0075	CcSEcCtD
Midodrine—Chills—Bleomycin—lymphatic system cancer	0.00746	0.00746	CcSEcCtD
Midodrine—Nausea—Mechlorethamine—lymphatic system cancer	0.00739	0.00739	CcSEcCtD
Midodrine—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00733	0.00733	CcSEcCtD
Midodrine—Abdominal pain—Teniposide—lymphatic system cancer	0.00725	0.00725	CcSEcCtD
Midodrine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00724	0.00724	CcSEcCtD
Midodrine—Dyspnoea—Fludarabine—lymphatic system cancer	0.00719	0.00719	CcSEcCtD
Midodrine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00709	0.00709	CcSEcCtD
Midodrine—Hepatic enzyme increased—Methotrexate—lymphatic system cancer	0.00708	0.00708	CcSEcCtD
Midodrine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00696	0.00696	CcSEcCtD
Midodrine—Pain—Fludarabine—lymphatic system cancer	0.00689	0.00689	CcSEcCtD
Midodrine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00687	0.00687	CcSEcCtD
Midodrine—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00684	0.00684	CcSEcCtD
Midodrine—Urethral disorder—Vincristine—lymphatic system cancer	0.00679	0.00679	CcSEcCtD
Midodrine—Flushing—Carmustine—lymphatic system cancer	0.00674	0.00674	CcSEcCtD
Midodrine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00664	0.00664	CcSEcCtD
Midodrine—Asthenia—Teniposide—lymphatic system cancer	0.00658	0.00658	CcSEcCtD
Midodrine—Pruritus—Teniposide—lymphatic system cancer	0.00649	0.00649	CcSEcCtD
Midodrine—Cardiac disorder—Vincristine—lymphatic system cancer	0.00643	0.00643	CcSEcCtD
Midodrine—Mental disorder—Carmustine—lymphatic system cancer	0.00636	0.00636	CcSEcCtD
Midodrine—Angiopathy—Vincristine—lymphatic system cancer	0.00629	0.00629	CcSEcCtD
Midodrine—Back pain—Carmustine—lymphatic system cancer	0.00611	0.00611	CcSEcCtD
Midodrine—Mental disorder—Vincristine—lymphatic system cancer	0.00607	0.00607	CcSEcCtD
Midodrine—Chills—Mitoxantrone—lymphatic system cancer	0.00606	0.00606	CcSEcCtD
Midodrine—Confusional state—Bleomycin—lymphatic system cancer	0.00596	0.00596	CcSEcCtD
Midodrine—Back pain—Vincristine—lymphatic system cancer	0.00584	0.00584	CcSEcCtD
Midodrine—Agitation—Carmustine—lymphatic system cancer	0.00581	0.00581	CcSEcCtD
Midodrine—Asthenia—Fludarabine—lymphatic system cancer	0.00578	0.00578	CcSEcCtD
Midodrine—Rash—Teniposide—lymphatic system cancer	0.00578	0.00578	CcSEcCtD
Midodrine—Dermatitis—Teniposide—lymphatic system cancer	0.00578	0.00578	CcSEcCtD
Midodrine—Headache—Teniposide—lymphatic system cancer	0.00574	0.00574	CcSEcCtD
Midodrine—Pruritus—Fludarabine—lymphatic system cancer	0.0057	0.0057	CcSEcCtD
Midodrine—Back pain—Mitoxantrone—lymphatic system cancer	0.00568	0.00568	CcSEcCtD
Midodrine—Agitation—Vincristine—lymphatic system cancer	0.00554	0.00554	CcSEcCtD
Midodrine—Hypertension—Carmustine—lymphatic system cancer	0.00546	0.00546	CcSEcCtD
Midodrine—Nausea—Teniposide—lymphatic system cancer	0.00545	0.00545	CcSEcCtD
Midodrine—Anxiety—Carmustine—lymphatic system cancer	0.00536	0.00536	CcSEcCtD
Midodrine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00531	0.00531	CcSEcCtD
Midodrine—Dyspnoea—Bleomycin—lymphatic system cancer	0.00527	0.00527	CcSEcCtD
Midodrine—Hypertension—Vincristine—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Midodrine—Confusional state—Carmustine—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Midodrine—Rash—Fludarabine—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Midodrine—Dermatitis—Fludarabine—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Midodrine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00507	0.00507	CcSEcCtD
Midodrine—Pain—Bleomycin—lymphatic system cancer	0.00505	0.00505	CcSEcCtD
Midodrine—Headache—Fludarabine—lymphatic system cancer	0.00505	0.00505	CcSEcCtD
Midodrine—Tachycardia—Carmustine—lymphatic system cancer	0.00503	0.00503	CcSEcCtD
Midodrine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00499	0.00499	CcSEcCtD
Midodrine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Midodrine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00484	0.00484	CcSEcCtD
Midodrine—Nervous system disorder—Vincristine—lymphatic system cancer	0.00483	0.00483	CcSEcCtD
Midodrine—Nausea—Fludarabine—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Midodrine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00468	0.00468	CcSEcCtD
Midodrine—Insomnia—Carmustine—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Midodrine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00466	0.00466	CcSEcCtD
Midodrine—Irritability—Methotrexate—lymphatic system cancer	0.00464	0.00464	CcSEcCtD
Midodrine—Paraesthesia—Carmustine—lymphatic system cancer	0.00463	0.00463	CcSEcCtD
Midodrine—Dyspnoea—Carmustine—lymphatic system cancer	0.0046	0.0046	CcSEcCtD
Midodrine—Somnolence—Carmustine—lymphatic system cancer	0.00459	0.00459	CcSEcCtD
Midodrine—Insomnia—Vincristine—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Midodrine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Midodrine—Paraesthesia—Vincristine—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Midodrine—Pain—Carmustine—lymphatic system cancer	0.00441	0.00441	CcSEcCtD
Midodrine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Midodrine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Midodrine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00426	0.00426	CcSEcCtD
Midodrine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00425	0.00425	CcSEcCtD
Midodrine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00425	0.00425	CcSEcCtD
Midodrine—Asthenia—Bleomycin—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Midodrine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Midodrine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Midodrine—Pain—Vincristine—lymphatic system cancer	0.00421	0.00421	CcSEcCtD
Midodrine—Pruritus—Bleomycin—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Midodrine—Pain—Mitoxantrone—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Midodrine—Abdominal pain—Carmustine—lymphatic system cancer	0.00408	0.00408	CcSEcCtD
Midodrine—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Midodrine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Midodrine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Midodrine—Dysuria—Methotrexate—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Midodrine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Midodrine—Abdominal pain—Vincristine—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Midodrine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Midodrine—Rash—Bleomycin—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Midodrine—Dermatitis—Bleomycin—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Midodrine—Asthenia—Carmustine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Midodrine—Stomatitis—Methotrexate—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Midodrine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Midodrine—Asthenia—Vincristine—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Midodrine—Nausea—Bleomycin—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Midodrine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Midodrine—Dizziness—Carmustine—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Midodrine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Midodrine—Urethral disorder—Methotrexate—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Midodrine—Dizziness—Vincristine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Midodrine—Rash—Carmustine—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Midodrine—Dermatitis—Carmustine—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Midodrine—Headache—Carmustine—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Midodrine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Midodrine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Midodrine—Rash—Vincristine—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Midodrine—Dermatitis—Vincristine—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Midodrine—Headache—Vincristine—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Midodrine—Nausea—Carmustine—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Midodrine—Angiopathy—Methotrexate—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Midodrine—Rash—Mitoxantrone—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Midodrine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Midodrine—Chills—Methotrexate—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Midodrine—Headache—Mitoxantrone—lymphatic system cancer	0.003	0.003	CcSEcCtD
Midodrine—Mental disorder—Methotrexate—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Midodrine—Nausea—Vincristine—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Midodrine—Nausea—Mitoxantrone—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Midodrine—Back pain—Methotrexate—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Midodrine—Confusional state—Methotrexate—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Midodrine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Midodrine—Skin disorder—Methotrexate—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Midodrine—Insomnia—Methotrexate—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Midodrine—Paraesthesia—Methotrexate—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Midodrine—Dyspnoea—Methotrexate—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Midodrine—Somnolence—Methotrexate—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Midodrine—Dyspepsia—Methotrexate—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Midodrine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Midodrine—Pain—Methotrexate—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Midodrine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Midodrine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Midodrine—Abdominal pain—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Midodrine—Asthenia—Methotrexate—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Midodrine—Pruritus—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Midodrine—Dizziness—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Midodrine—Rash—Methotrexate—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Midodrine—Dermatitis—Methotrexate—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Midodrine—Headache—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Midodrine—Nausea—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
